E. Gezer Et Al. , "Cyp3a4 *1b gene polymorphism in coronary artery disease patients with obesity undergoing statin treatment," Current Pharmacogenomics and Personalized Medicine , vol.18, no.1, pp.18-23, 2021
Gezer, E. Et Al. 2021. Cyp3a4 *1b gene polymorphism in coronary artery disease patients with obesity undergoing statin treatment. Current Pharmacogenomics and Personalized Medicine , vol.18, no.1 , 18-23.
Gezer, E., Cevik, M., Akdeniz, C. S., Canbolat, I. P., Yurdakul, S., SÜNBÜL, M., ... Cagatay, P.(2021). Cyp3a4 *1b gene polymorphism in coronary artery disease patients with obesity undergoing statin treatment. Current Pharmacogenomics and Personalized Medicine , vol.18, no.1, 18-23.
Gezer, Elifcan Et Al. "Cyp3a4 *1b gene polymorphism in coronary artery disease patients with obesity undergoing statin treatment," Current Pharmacogenomics and Personalized Medicine , vol.18, no.1, 18-23, 2021
Gezer, Elifcan Et Al. "Cyp3a4 *1b gene polymorphism in coronary artery disease patients with obesity undergoing statin treatment." Current Pharmacogenomics and Personalized Medicine , vol.18, no.1, pp.18-23, 2021
Gezer, E. Et Al. (2021) . "Cyp3a4 *1b gene polymorphism in coronary artery disease patients with obesity undergoing statin treatment." Current Pharmacogenomics and Personalized Medicine , vol.18, no.1, pp.18-23.
@article{article, author={Elifcan Gezer Et Al. }, title={Cyp3a4 *1b gene polymorphism in coronary artery disease patients with obesity undergoing statin treatment}, journal={Current Pharmacogenomics and Personalized Medicine}, year=2021, pages={18-23} }